<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
Filed pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934 and Rule 13a-17
or 15d-17 thereunder
CELGENE CORPORATION
(Exact name of issuer as specified in charter)
7 POWDER HORN DRIVE, WARREN, NJ 07059
(Address of principal executive offices)
Issuer's telephone number, including area code: (908) 271-1001
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of five percent or more in the
number of shares outstanding:
1. Title of security: Common Stock, par value $.01 per share
2. Number of shares outstanding before the change: 8,261,216
3. Number of shares outstanding after the change: 8,708,062
4. Effective date of change: November 8, 1995.
5. Method of change: Conversion of convertible debentures into shares of common
stock and exercise of employee stock options.
Give brief description of transaction: From October 13, 1995 (the effective date
of the last report) through November 8, 1995, an additional 425,185 shares of
common stock had been issued as a result of conversions of convertible
debentures. In addition, 21,661 shares of common stock had been issued as a
result of exercise of employee stock options.
II. CHANGE IN NAME OF ISSUER [Not Applicable]
1. Name prior to change _______________________________________
2. Name after change __________________________________________
3. Effective date of character amendment changing name ________
4. Date of shareholder approval of change, if required ________
CELGENE CORPORATION
Date: November 8, 1995 By: /s/ Robert Eastty
------------------
Robert Eastty
Controller and
Assistant Secretary
